Patents Assigned to La Jolla Pharma, LLC
  • Methods for administering angiotensin II
    Patent number: 11583568
    Abstract: The present disclosure relates to the use of angiotensin II, angiotensin III, or angiotensin IV in therapeutic methods for the treatment of hypotension, especially catecholamine-resistant hypotension.
    Type: Grant
    Filed: April 13, 2018
    Date of Patent: February 21, 2023
    Assignee: La Jolla Pharma, LLC
    Inventors: Lakhmir Chawla, George Tidmarsh, Steve Ching Tsung Chen
  • Methods for treating hypotension in a patient that has received an ACE inhibitor by administering angiotensin II
    Patent number: 11219662
    Abstract: The present disclosure relates to the use of angiotensin II, angiotensin III, or angiotensin IV in therapeutic methods for the treatment of hypotension, especially catecholamine-resistant hypotension.
    Type: Grant
    Filed: March 4, 2021
    Date of Patent: January 11, 2022
    Assignee: La Jolla Pharma, LLC
    Inventors: George Tidmarsh, Lakhmir Chawla
  • Methods for administering angiotensin II
    Patent number: 10406201
    Abstract: The present disclosure relates to the use of angiotensin II, angiotensin III, or angiotensin IV in therapeutic methods for the treatment of hypotension, especially catecholamine-resistant hypotension.
    Type: Grant
    Filed: January 6, 2017
    Date of Patent: September 10, 2019
    Assignee: La Jolla Pharma, LLC
    Inventors: George Tidmarsh, Lakhmir Chawla